Loading

Press Release

American Society of Radiologic Technologists Approves Sensus Healthcare’s SRT Systems for Continuing Education Units

American Society of Radiologic Technologists Approves Sensus Healthcare’s SRT Systems for Continuing Education Units

Beginning September 1, Category A credits will be available for in-person trainings on the SRT-100™, SRT-100+™ and SRT-100 Vision™ systems…

See More
Sensus Healthcare Acquires Two Mobile Aesthetic Laser Companies in Florida

Sensus Healthcare Acquires Two Mobile Aesthetic Laser Companies in Florida

Establishes new line of business, adds recurring revenue stream while more than doubling dermatology customer base across the state Expected…

See More
Sensus Healthcare Names Hoi-Bun “Benson” Suen Vice President of International Sales, Ships SRT-100™ to China

Sensus Healthcare Names Hoi-Bun “Benson” Suen Vice President of International Sales, Ships SRT-100™ to China

BOCA RATON, Fla. (July 28, 2020) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective,…

See More
ASTRO Defines SRT as a First Line Treatment for Non-Melanoma Skin Cancer

ASTRO Defines SRT as a First Line Treatment for Non-Melanoma Skin Cancer

Influential professional organization recommends radiotherapy as the primary non-surgical alternative for patients with basal cell or cutaneous squamous cell carcinomas…

See More
South Florida Business Journal: Executive Profile: Sensus Healthcare CEO Joe Sardano

South Florida Business Journal: Executive Profile: Sensus Healthcare CEO Joe Sardano

Our CEO, Chairman, and Founder Joe Sardano, sat down with South Florida Business Journal’s (SFPJ) digital editor Emon Reiser to…

See More
Sensus Healthcare Announces Publication of Research on Long-term Efficacy and Safety of Superficial Radiation Therapy in Journal of Drugs in Dermatology

Sensus Healthcare Announces Publication of Research on Long-term Efficacy and Safety of Superficial Radiation Therapy in Journal of Drugs in Dermatology

Retrospective registry study showed a 98.9% non-recurrence rate after 85 months in subjects with non-melanoma skin cancer treated with SRT…

See More
Sensus Healthcare Announces Sculptura™ Shipment to California-based Medical Center Third Sculptura system sold worldwide

Sensus Healthcare Announces Sculptura™ Shipment to California-based Medical Center Third Sculptura system sold worldwide

BOCA RATON, Fla, Jan. 22, 2020 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly…

See More
Sensus Healthcare Awarded Brachytherapy Products Agreement with Premier

Sensus Healthcare Awarded Brachytherapy Products Agreement with Premier

Sensus Healthcare, Inc. has been awarded a group purchasing agreement for Brachytherapy Products with Premier. Effective August 1, 2019, the…

See More
Five-Year Retrospective Study Shows Topline Results for Patients Treated with Sensus Healthcare’s Superficial Radiation Therapy

Five-Year Retrospective Study Shows Topline Results for Patients Treated with Sensus Healthcare’s Superficial Radiation Therapy

Sensus Healthcare, Inc. announces topline results from a five-year retrospective study of non-melanoma skin cancer (NMSC) patients treated with Superficial…

See More
Sensus Healthcare Launches SRT University, an Online Portal to Support Physicians

Sensus Healthcare Launches SRT University, an Online Portal to Support Physicians

Sensus Healthcare, Inc. launches SRT University, an online portal to support physicians using Sensus devices and technology. The new online…

See More
Sensus Healthcare Announces FDA Market Clearance for Sensus Healthcare’s New Sculptura™ Radiation Oncology System

Sensus Healthcare Announces FDA Market Clearance for Sensus Healthcare’s New Sculptura™ Radiation Oncology System

Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced…

See More
Sensus Healthcare Profiled in Future Market Insights Report–Global Keloid Treatment Market to Collect $4,414.6 Million by 2027 End

Sensus Healthcare Profiled in Future Market Insights Report–Global Keloid Treatment Market to Collect $4,414.6 Million by 2027 End

Valley Cottage, New York, Oct. 30, 2017 (GLOBE NEWSWIRE) — According to the latest market report published by FMI titled…

See More
Sensus Healthcare Announces Low 3% Keloid Recurrence in Multicenter Case Series of 297 Patients Treated with Superficial Radiation Therapy

Sensus Healthcare Announces Low 3% Keloid Recurrence in Multicenter Case Series of 297 Patients Treated with Superficial Radiation Therapy

SRT-100, a Low-energy X-ray Technology, Used at Site of Keloidectomy Treatment BOCA RATON, Fla., Dec. 6, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a…

See More
Sensus Healthcare Installs First Groundbreaking SRT-100+ Superficial Radiation Therapy System for Treating Keloid Scars

Sensus Healthcare Installs First Groundbreaking SRT-100+ Superficial Radiation Therapy System for Treating Keloid Scars

Dr. Kenrick Spence of Hillcrest Plastic Surgery in Orlando First to Offer System BOCA RATON, Fla., Nov. 29, 2018,/PRNewswire/ — Sensus…

See More
Sensus Healthcare Receives FDA 501(k) Clearance to Market Next-Generation SRT-100+ Superficial Radiation Therapy for Treating Non-Melanoma Skin Cancer and Keloids

Sensus Healthcare Receives FDA 501(k) Clearance to Market Next-Generation SRT-100+ Superficial Radiation Therapy for Treating Non-Melanoma Skin Cancer and Keloids

SRT-100+ Offers Advanced Features for Patients and Doctors, Including Remote Diagnostics and Patient Medical Records Integration, as well as Core…

See More
Sensus Healthcare Brings Groundbreaking SRT-100 Vision System to Israel’s Largest Hospital for Skin Cancer and Keloid Treatment

Sensus Healthcare Brings Groundbreaking SRT-100 Vision System to Israel’s Largest Hospital for Skin Cancer and Keloid Treatment

BOCA RATON, Fla., Oct. 17, 2018 /PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin…

See More
South Florida Business Journal Recognizes Sensus Healthcare’s Chief Technology Officer at 2018 Technology Awards

South Florida Business Journal Recognizes Sensus Healthcare’s Chief Technology Officer at 2018 Technology Awards

BOCA RATON, Fla., Oct. 16, 2018,/PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin…

See More
Sensus Healthcare Presents at National Cancer Care Alliance Leadership Board and Practice Quarterly Meeting

Sensus Healthcare Presents at National Cancer Care Alliance Leadership Board and Practice Quarterly Meeting

BOCA RATON, Fla., Sept. 7, 2018,/PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ : SRTS ), a medical device company specializing in the non-invasive treatment of…

See More
Sensus Healthcare Announces Strategic Agreement with SkinCure Oncology

Sensus Healthcare Announces Strategic Agreement with SkinCure Oncology

BOCA RATON, Fla., July 12, 2018,/PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin…

See More
Sensus Healthcare to Join Russell Microcap® Index

Sensus Healthcare to Join Russell Microcap® Index

BOCA RATON, Fla., June 25, 2018,/PRNewswire/ — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma…

See More

Contact Us

Fill out the form below to find out more!